Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio製藥公司股價上漲,此前HC Wainwright&Co.將該公司股票評級從中性上調至買入,並宣佈了22美元的目標價。
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio製藥公司股價上漲,此前HC Wainwright&Co.將該公司股票評級從中性上調至買入,並宣佈了22美元的目標價。